Dean McGee Eye Institute has partnered with OU Health to become one of 17 centers in the US to offer a new treatment, Luxturna, to reverse vision loss in patients.
While not every form of blindness can be cured, recent scientific breakthroughs have uncovered new ways to treat some forms of inherited blindness through gene therapy.
scAAVengr is a powerful computational platform that is used for the development of adeno-associated virus vector (AAV). It is best suited for the task of delivering a gene therapy to a specific part of the retina.